A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Bicara Therapeutics
Xencor, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Klus Pharma Inc.
Theratechnologies
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
National University Hospital, Singapore
AIDS Malignancy Consortium
Canadian Cancer Trials Group
Mitra RxDx, Inc.
Dana-Farber Cancer Institute
University of Arizona
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Rutgers, The State University of New Jersey